Trust Company of Vermont’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.92M Buy
24,311
+2,728
+13% +$214K 0.08% 144
2025
Q3
$1.73M Buy
21,583
+238
+1% +$20.3K 0.08% 147
2025
Q2
$1.94M Buy
21,345
+725
+4% +$66.2K 0.09% 143
2025
Q1
$1.93M Sell
20,620
-7,130
-26% -$638K 0.1% 139
2024
Q4
$2.52M Sell
27,750
-86
-0.3% -$8.21K 0.12% 123
2024
Q3
$2.89M Sell
27,836
-1,612
-5% -$164K 0.14% 115
2024
Q2
$2.86M Sell
29,448
-185
-0.6% -$17.1K 0.16% 110
2024
Q1
$2.67M Buy
29,633
+7,479
+34% +$634K 0.15% 118
2023
Q4
$1.77M Sell
22,154
-9,530
-30% -$717K 0.12% 127
2023
Q3
$2.25M Sell
31,684
-605
-2% -$45.2K 0.15% 119
2023
Q2
$2.49M Buy
32,289
+1,774
+6% +$137K 0.16% 123
2023
Q1
$2.29M Sell
30,515
-772
-2% -$57.4K 0.16% 127
2022
Q4
$2.47M Buy
31,287
+120
+0.4% +$9K 0.18% 121
2022
Q3
$2.19M Buy
31,167
+2,294
+8% +$180K 0.17% 121
2022
Q2
$2.31M Sell
28,873
-446
-2% -$34.9K 0.18% 121
2022
Q1
$2.22M Sell
29,319
-376
-1% -$29.8K 0.15% 128
2021
Q4
$2.53M Sell
29,695
-5,292
-15% -$413K 0.16% 124
2021
Q3
$2.65M Sell
34,987
-302
-0.9% -$24K 0.19% 120
2021
Q2
$2.87M Sell
35,289
-1,161
-3% -$94.9K 0.2% 115
2021
Q1
$2.87M Sell
36,450
-566
-2% -$44.4K 0.22% 108
2020
Q4
$3.17M Sell
37,016
-1,219
-3% -$101K 0.25% 101
2020
Q3
$2.95M Sell
38,235
-722
-2% -$55K 0.27% 95
2020
Q2
$2.85M Sell
38,957
-5,021
-11% -$357K 0.28% 91
2020
Q1
$2.92M Sell
43,978
-418
-0.9% -$29.5K 0.27% 90
2019
Q4
$3.06M Sell
44,396
-679
-2% -$46.3K 0.23% 100
2019
Q3
$3.31M Sell
45,075
-250
-0.6% -$18.1K 0.27% 94
2019
Q2
$3.25M Sell
45,325
-1,088
-2% -$77.2K 0.27% 92
2019
Q1
$3.18M Sell
46,413
-909
-2% -$58.7K 0.27% 91
2018
Q4
$2.82M Sell
47,322
-1,825
-4% -$114K 0.27% 92
2018
Q3
$3.29M Sell
49,147
-482
-1% -$32.1K 0.28% 92
2018
Q2
$3.22M Sell
49,629
-2,977
-6% -$195K 0.29% 92
2018
Q1
$3.77M Buy
52,606
+635
+1% +$45.7K 0.36% 80
2017
Q4
$3.92M Sell
51,971
-284
-0.5% -$20.7K 0.36% 82
2017
Q3
$3.81M Sell
52,255
-875
-2% -$63.1K 0.38% 75
2017
Q2
$3.94M Sell
53,130
-546
-1% -$40.5K 0.4% 74
2017
Q1
$3.93M Buy
53,676
+747
+1% +$52.3K 0.42% 71
2016
Q4
$3.46M Buy
52,929
+4,087
+8% +$280K 0.4% 74
2016
Q3
$3.62M Buy
48,842
+1,647
+3% +$122K 0.45% 71
2016
Q2
$3.46M Buy
47,195
+782
+2% +$55.7K 0.46% 76
2016
Q1
$3.28M Buy
46,413
+481
+1% +$32K 0.46% 74
2015
Q4
$3.06M Buy
45,932
+1,931
+4% +$128K 0.44% 76
2015
Q3
$2.79M Buy
44,001
+45
+0.1% +$2.94K 0.43% 74
2015
Q2
$2.88M Sell
43,956
-399
-0.9% -$27.1K 0.42% 76
2015
Q1
$3.08M Buy
44,355
+263
+0.6% +$18.2K 0.45% 71
2014
Q4
$3.05M Buy
44,092
+547
+1% +$36.9K 0.44% 70
2014
Q3
$2.84M Sell
43,545
-187
-0.4% -$12.3K 0.43% 73
2014
Q2
$2.98M Sell
43,732
-55
-0.1% -$3.69K 0.46% 70
2014
Q1
$2.84M Sell
43,787
-321
-0.7% -$20.2K 0.47% 66
2013
Q4
$2.88M Sell
44,108
-1,981
-4% -$127K 0.48% 68
2013
Q3
$2.73M Buy
46,089
+545
+1% +$32.3K 0.5% 66
2013
Q2
$2.61M Buy
+45,544
New +$2.7M 0.51% 65

Other funds holding CL

Trust Company of Vermont's CL Position: Q4 2025 in Review

Trust Company of Vermont increased its Colgate-Palmolive (CL) stake by 13% in Q4 2025, buying an estimated $214K and bringing the position to 24,311 shares worth $1.92M. The position accounts for 0.08% of the portfolio, ranked #144.

Trust Company of Vermont first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.94M in Q2 2017. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Trust Company of Vermont held 24,311 shares of Colgate-Palmolive worth $1.92M as of Q4 2025.
  • Trust Company of Vermont bought 2,728 Colgate-Palmolive shares in Q4 2025, an estimated $214K.
  • Colgate-Palmolive made up 0.08% of Trust Company of Vermont's portfolio in Q4 2025, its #144 holding.
  • Trust Company of Vermont first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
  • Trust Company of Vermont's Colgate-Palmolive position peaked at $3.94M in Q2 2017.
  • 1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.